Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs. The company focuses on microRNA-based therapeutic interventions.
2 investors
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach. The company targets severe autoimmune and inflammatory disorders for patients with immune-mediated conditions.
2 investors
Arum Therapeutics is a drug development company focused on identifying and targeting novel biological targets and signaling pathways to create new therapeutics.
2 investors
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.
2 investors
AskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
2 investors
Assembly Bio is a biopharmaceutical company developing novel therapeutic candidates for viral and liver diseases, including programs targeting herpesviruses, hepatitis delta virus, hepatitis B virus, and cholestatic liver diseases.
2 investors
Astonishing Labs partners with university lab scientists to commercialize early-stage biological research and build biotech platform companies aimed at developing new therapies. It focuses on funding research that departs from established scientific conventions, working at the earliest stage of the innovation life cycle.
2 investors
bioMรฉrieux develops in vitro diagnostic systems and molecular testing panels for pathogen detection in clinical, food safety, and pharmaceutical quality control settings. The company serves healthcare providers, laboratories, food industry, and pharmaceutical manufacturers with rapid PCR-based diagnostic solutions.
2 investors
่ฏๅฎฟ็งๆ (Atantares) develops molecular chips using semiconductor technologies such as integrated circuits, CMOS and MEMS to enable high-throughput, low-cost synthesis and detection of DNA, RNA and proteins. It offers a gene synthesis platform and services including primer synthesis, gene synthesis, sequencing, cloning and mutation, strain library preparation and gene editing, along with its EcoSyn electrochemical oligonucleotide synthesizer.
2 investors
Atea is a clinical-stage biopharmaceutical company developing oral direct-acting antiviral therapies for single-stranded RNA viruses, currently focused on a bemnifosbuvir and ruzasvir regimen in Phase 3 development for hepatitis C virus (HCV). Its work spans antiviral drug discovery, medicinal chemistry, biology, and virology.
2 investors
2 investors
2 investors
Atlas builds a foundational model of human biology used to predict patient outcomes and run virtual clinical trials. It serves drug developers and clinical program teams seeking to improve trial success and reduce costs.
2 investors
AtlasBase builds a hybrid Bio-Silicon platform that stores digital data in synthetic DNA and performs computation directly within the molecules, offering petabyte-scale archives with near-zero power and long-term durability. It targets enterprises needing massive data archiving and parallel molecular computation.
2 investors
Atomo Diagnostics develops diagnostic ecosystems and mobile applications for point-of-care testing, including whole-blood cassettes and reader devices compatible with smartphones for remote diagnostics. The company serves clinicians and self-test users in the in-vitro diagnostics and digital health markets.
2 investors
Atterx develops novel pharmaceutical therapies to prevent and treat antibiotic-resistant bacterial infections using bacterial interference and conjugation technologies. The company targets multi-drug resistant infections through specialty pharmaceutical products designed for clinical development.
2 investors
Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients. The company works in the biotech and drug development field across specific disease areas.
2 investors
Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.
2 investors
Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.
2 investors
่ไนๅฅๅบท็งๆ (AuroraPrime) is an AI platform for the life sciences and pharmaceutical industry that automates the generation of regulatory and medical documents such as clinical study reports, protocols, and safety narratives across the R&D lifecycle. It also offers Intelligent EDC and medical monitoring tools for pharmaceutical companies, CROs, and research organizations.
2 investors
AutoPhagyGO is a biotech company focused on autophagy research with applications in longevity and age-related disease prevention and treatment. The company leverages cellular regeneration mechanisms to develop therapeutics that promote healthy aging.
2 investors
Auxilius provides software and expert services to manage clinical R&D operations and financial processes for biotech companies. The platform automates budgeting, forecasting, and financial close procedures to reduce clinical trial failures caused by operational complexity.
2 investors
Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment. The company operates in the medical diagnostics field with an emphasis on technology and science.
2 investors
2 investors